Citations 17

Frequency of Optic Nerve Enhancement During Acute Optic Neuritis in MOG Antibody-associated Disease (S6.004)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215356

Outcomes of Maintenance Immunotherapy in a Cohort of Patients With Susac Syndrome

Neurology Clinical Practice | October 2, 2025 | Volume: 15 | Issue: 6 | Pages: No page available

10.1212/cpj.0000000000200544 | PMID 41070138

Amaurosis Fugax Dolorosa

Neurology Neuroimmunology & Neuroinflammation | September 22, 2025 | Volume: 12 | Issue: 6 | Pages: No page available

10.1212/nxi.0000000000200471 | PMID 40982779

Unveiling Misdiagnosis: Rethinking Seronegative NMOSD

Multiple Sclerosis Journal | August 16, 2025 | Volume: 31 | Issue: 11 | Pages: 1381-1384

10.1177/13524585251360648 | PMID 40817768

Seronegative neuromyelitis optica spectrum disorder (NMOSD) is a diagnostic challenge. This study aimed to characterize misapplication of the 2015 international criteria for seronegative NMOSD. We reviewed 35 consecutive seronegative NMOSD referrals to a tertiary center. Two (6%) met formal criteria, and 2 (6%) were clinically suspected of NMOSD without fulfilling radiologic supportive criteria. Alternative diagnoses were common including multiple sclerosis (37%), optic neuritis (14%), functional neurologic disorder (11%), and other (38%). Immunosuppression with rituximab was used in 3 of 4 patients with functional neurologic disorder. Misapplication of the 2015 criteria is common, and alternative explanations in seronegative NMOSD patients should be strongly considered.
Assessment of increased opening pressure in patients with multiple sclerosis and aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder

Multiple Sclerosis Journal | May 26, 2025 | Volume: 31 | Issue: 10 | Pages: 1247-1253

10.1177/13524585251340841 | PMID 40415648

Increased intracranial pressure (ICP) is increasingly recognized in myelin oligodendrocyte glycoprotein antibody-associated disease but has not been systematically explored in other demyelinating conditions. This cross-sectional study examines the features of raised ICP in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS). Lumbar puncture opening pressure (OP) done within 30 days of an attack was identified in 41 NMOSD patients and 37 MS patients. Raised OP was present in 7 (17.1%) NMOSD patients and 4 (10.8%) MS patients who were largely asymptomatic, partially explained by obesity, and did not require ICP lowering medications beyond acute treatment with corticosteroids.
Clinical Features and Factors Associated With Outcome in Late Adult-Onset Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

Neurology | May 5, 2025 | Volume: 104 | Issue: 10 | Pages: No page available

10.1212/wnl.0000000000213557 | PMID 40324120

Venous Sinus Stenting Outcomes in Patients with Papilledema from Secondary Causes of Elevated Intracranial Pressure

Neuro-Ophthalmology | April 28, 2025 | Volume: 49 | Issue: 4 | Pages: 306-312

10.1080/01658107.2025.2495303 | PMID 42422407

Evaluating Long-term Outcomes of Venous Sinus Stenting in Idiopathic Intracranial Hypertension (P5-11.016)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000208572

Dynamic Optic Nerve MRI Changes in Acute Optic Neuritis in MOG Antibody-Associated Disease (P11-8.006)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000211231

Late Adult Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Clinical Characterization and Predictors of Outcome (P7-8.005)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000211822